Meeting
2012 ASCO Annual Meeting
Incidence and prognostic impact of KRAS and BRAF mutations in patients undergoing liver surgery for colorectal metastases.
Authors
Georgios Karagkounis
The Johns Hopkins University School of Medicine, Baltimore, MD
Georgios Karagkounis , Michael S. Torbenson , Hubert D Daniel , Nilofer Saba Azad , Luis A. Diaz Jr., Ross C. Donehower , Kenzo Hirose , Timothy M. Pawlik , Michael A. Choti
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer
Citation
J Clin Oncol 30, 2012 (suppl; abstr 3616)
DOI
10.1200/jco.2012.30.15_suppl.3616
Abstract #
3616
Poster Bd #
36E
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Clinical evolution after surgery of hepatic metastases of colorectal cancer according to genomic profile.
First Author: Blanca Morón García
Poster
2021 ASCO Annual Meeting
The prognostic impact of RAS and TP53 mutation according to primary tumor location in colorectal liver metastases.
First Author: Yongjun Cha
Poster
2018 ASCO Annual Meeting
What is the prognostic impact of BRAF mutation in patients undergoing resection of colorectal liver metastases? Results of nationwide intergroup (ACHBT, FRENCH, AGEO) cohort of 249 patients.
First Author: Jean-Baptiste Bachet
Poster
2016 ASCO Annual Meeting
KRAS and BRAF as prognostic biomarkers in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis.
First Author: Francesco Passiglia